Time: 12:00 - 1:00pm
Speaker: Dr Shiladitya Sengupta, Harvard Medical School, Boston
Venue: GC 201, Graduate Centre
In this inaugural Sir Peter Mansfield Lecture, Dr Shiladitya Sengupta of Harvard Medical School, Boston will deliver a lecture titled 'Challenges in Treating Cancer: New Insights and Opportunities'.
Dr. Shiladitya Sengupta is an associate professor of medicine at Harvard Medical School and the Director of the Center for Engineered Therapeutics at the Brigham and Women’s Hospital, Principal Investigator at Dana Farber Cancer Institute and faculty member at the Harvard-MIT Division of Health Sciences and Technology. His laboratory focuses on translational research, bridging clinical needs with basic science, drug discovery, and biological engineering, with a special interest in drug response, tumor stromal interactions and metastasis. Dr. Sengupta founded Vyome Therapeutics Inc, Mitra Biotech, Akamara Therapeutics and Cerulean Pharmaceuticals. He serves as the chairman of the scientific advisory board of Advamedica, a medical device company.
Dr. Sengupta received his early training in medical pharmacology from the All India Institute of Medical Sciences, his PhD in Pharmacology from the University of Cambridge, where he was a Nehru and British Chevening Scholar at Trinity College, and his fellowship in Biological Engineering at Massachusetts Institute of Technology. Dr. Sengupta has been recognized as one of the top 35 Innovators of the world under 35 by MIT Technology Review Magazine, and is a recipient of the Era of Hope Scholar Award from the US Department of Defense, Coulter Foundation Career Award, and Young Scientist awards from the American Society for Pharmacology and Experimental Therapeutics.
About the Sir Peter Mansfield Lecture series
Barriers in translating research discoveries into successful businesses are well recognised and commonly termed ‘the valley of death’ in the start-up world. This lecture series will showcase how established entrepreneurs have successfully realised the commercial potential of their fundamental research discoveries. The series aims to highlight models for innovation and entrepreneurship within the University research environment. Both hurdles and rewards experienced through building impactful and sustainable industrial research programs will be explored.